DAUNORUBICIN HYDROCHLORIDE
Generic: DAUNORUBICIN HYDROCHLORIDE
Hikma Pharmaceuticals USA Inc.Manufacturer
INTRAVENOUSRoute
DAUNORUBICIN HYDROCHLORIDEActive Substance
1998-01-30Original Approval
DAUNORUBICIN HYDROCHLORIDE is FDA application NDA050731, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FEBRILE NEUTROPENIA
205 reports
2
MYELOSUPPRESSION
187 reports
3
BACTERIAL INFECTION
158 reports
4
SECONDARY IMMUNODEFICIENCY
130 reports
5
PYREXIA
127 reports
6
CLOSTRIDIUM DIFFICILE COLITIS
115 reports
7
OFF LABEL USE
109 reports
8
PANCYTOPENIA
95 reports
9
FUNGAL INFECTION
91 reports
10
VIRAL INFECTION
86 reports